J&J's Stelara Gets EU Nod for Plaque Psoriasis in Children
http://www.zacks.com/stock/news/731608/jjs-stelara-gets-eu-nod-for-plaque-psoriasis-in-children?cid=CS-ZC-FT-analyst_blog|company_news_-_medical_sector-731608
Jan 24, 2020 - Johnson & Johnson (JNJ) receives the European Commission's (EC) nod to the line extension of Stelara to treat six to 11-year-old pediatric patients with moderate-to-severe plaque psoriasis.
0
Top Stock Analyst Reports for Pfizer, Wells Fargo & SAP
http://www.zacks.com/research-daily/729250/top-stock-analyst-reports-for-pfizer-wells-fargo-sap?cid=CS-ZC-FT-research_daily-729250
Jan 22, 2020 - Top Stock Analyst Reports for Pfizer, Wells Fargo & SAP
0
Eli Lilly's Shopping Spree Won't Stop With Dermira, CFO Shares Plans For More Deals In 2020
https://www.fool.com/investing/2020/01/17/eli-lillys-shopping-spree-wont-stop-with-dermira-c.aspx?source=iedfolrf0000001
Jan 17, 2020 - The Midwest's largest drugmaker isn't finished making mid-sized deals.
0
Related Companies
| Name | Exchange | Price | Mkt Cap | |
| NVO | Novo Nordisk A/S | NYSE | $47.64 | $114.84B |
| SNY | Sanofi | NYSE | $43.75 | $109.14B |
| ABT | Abbott Laboratories | NYSE | $67.67 | $118.71B |
| BMY | Bristol-Myers Squibb Company | NYSE | $61.3 | $100.03B |
| GSK | GlaxoSmithKline PLC | NYSE | $39.21 | $97.25B |